Jackson Laboratory Cancer Center scientists are combining human cancer genomics with mouse biology and genetics expertise to interrogate cancer in clinically meaningful ways.
New research shows that a cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.
The National Institute of General Medical Sciences has awarded Petko Petkov a four-year grant totaling $1,385,337 to exploit the new methods he has developed to profile and investigate zinc finger proteins and their binding sites.
New five-year, $2.2M outstanding investigator grant to Mingyang Lu will support systems biology algorithm approach.
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
The members of the American Association for Cancer Research have elected Jackson Laboratory President and CEO Edison T. Liu, M.D. to serve on the AACR Board of Directors for the 2018-2021 term.
Chang studies cell metabolism in tumor and immune cells, with the aim of developing new treatment approaches for cancers and immunologic diseases.
Two grants from the U.S. Department of Defense totaling $2.8 million will support Jackson Laboratory (JAX) research in one of the most deadly forms of breast cancer, known as triple-negative breast cancer.
A new approach to treating some leukemias could deliver a one-two punch to the cancer cells without harming normal tissue.
Assistant Professor Christine Beck, Ph.D., is uncovering how recurring sequences in our genomes might shed light on genome stability, as well as diseases like cancer.
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
First global online catalog of Patient-Derived Xenograft models helps cancer researchers save valuable time.
An invisible ally in the fight against cancer? Researchers find evidence that healthy skin microbiomes contain a bacterial strain that helps prevent cancer from growing.
A cancer patient’s genetic profile may influence whether or not he or she will have a toxic response to a given chemotherapy, Jackson Laboratory researchers report in The Pharmacogenomics Journal.